Gland Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Dec' 23	Sep' 23	Jun' 23	Mar' 23	Dec' 22

Sales

1,097.86

1,010.67

884.07

785.42

925.90

Operating profit

369.49

347.10

259.36

169.15

283.96

Interest

0.80

0.91

1.60

2.18

2.62

Gross profit

412.08

387.30

292.97

205.91

342.85

EPS (Rs)

16.81

15.64

11.39

4.81

13.82

Other income

43.39

41.11

35.21

38.94

61.51

Stock adjustment

103.70

-22.74

-20.49

-76.69

-15.85

Raw material

378.43

456.63

391.80

438.38

433.20

Power and fuel

28.62

-

-

29.51

-

Employee expenses

99.29

99.88

102.91

100.02

100.52

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

118.34

129.80

150.49

125.05

124.08

Provisions made

-

-

-

-

-

Depreciation

40.33

40.24

38.98

37.54

37.61

Taxation

94.95

89.54

66.41

32.70

77.70

Net profit / loss

276.81

257.53

187.58

79.21

227.54

Extra ordinary item

-

-

-

-56.46

-

Prior year adjustments

-

-

-

-

-

Equity capital

16.47

16.47

16.47

16.47

16.47

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

33.66

34.34

29.34

21.54

30.67

GPM (%)

36.11

36.82

31.87

24.98

34.72

NPM (%)

24.25

24.48

20.41

9.61

23.04